Description and Brand Names
US Brand Name
Satralizumab-mwge injection is used to treat neuromyelitis optic spectrum disorder (NMOSD), a rare disorder that causes inflammation of the nerves of the eyes and spinal cord. It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms: